Profile data is unavailable for this security.
About the company
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis and related lab services (U.S. dialysis) business treats patients with chronic kidney failure, end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and also includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
- Revenue in USD (TTM)12.52bn
- Net income in USD859.62m
- Incorporated1994
- Employees70.00k
- LocationDaVita Inc2000 16th StDENVER 80202-5158United StatesUSA
- Phone+1 (310) 536-2668
- Fax+1 (302) 636-5454
- Websitehttps://www.davita.com/
Mergers & acquisitions
Acquired company | DVA:NYQ since announced | Transaction value |
---|---|---|
Fresenius Medical Care AG & Co KGaA-Dialysis Clinic Network,Brazil | 29.71% | 300.00m |
Fresenius Medical Care AG & Co KGaA-Dialysis Clinic Network,Ecuador | 29.71% | -- |
Fresenius Medical Care AG & Co KGaA-Dialysis Clinic Network,Colombia | 29.71% | -- |
Fresenius Medical Care AG & Co KGaA-Dialysis Clinic Network,Chile | 29.71% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acadia Healthcare Company Inc | 3.06bn | -5.12m | 7.27bn | 23.50k | -- | 1.96 | 50.10 | 2.38 | -0.0725 | -0.0725 | 33.37 | 32.21 | 0.5647 | -- | 8.32 | 179,836.80 | 0.0705 | 2.32 | 0.0792 | 2.64 | -- | -- | 0.1249 | 5.60 | 1.17 | 5.44 | 0.3754 | -- | 12.20 | 8.99 | -107.93 | -- | 3.34 | -- |
Chemed Corp | 2.34bn | 300.92m | 8.71bn | 15.09k | 30.38 | 7.44 | 23.98 | 3.73 | 19.72 | 19.72 | 153.01 | 80.51 | 1.44 | 133.42 | 15.30 | 154,805.90 | 18.57 | 19.53 | 22.49 | 24.64 | 35.96 | 34.60 | 12.88 | 12.60 | 1.73 | -- | 0.00 | 8.15 | 6.06 | 4.90 | 9.17 | 5.80 | 1.46 | 6.10 |
Ensign Group Inc | 3.97bn | 225.40m | 8.72bn | 35.30k | 36.92 | 4.96 | 28.72 | 2.20 | 3.90 | 3.90 | 68.75 | 29.05 | 0.9458 | -- | 7.99 | 112,397.30 | 5.39 | 6.45 | 6.43 | 7.88 | 21.36 | 22.32 | 5.69 | 6.48 | -- | 354.48 | 0.0815 | 6.56 | 23.27 | 16.28 | -6.80 | 28.62 | 4.40 | 5.02 |
Encompass Health Corp | 5.07bn | 409.00m | 9.42bn | 22.36k | 23.92 | 5.25 | 11.62 | 1.86 | 4.01 | 3.89 | 49.78 | 18.28 | 0.8279 | -- | 9.04 | 226,825.00 | 8.65 | 6.37 | 11.01 | 7.94 | 95.49 | 95.58 | 10.45 | 9.16 | -- | 5.90 | 0.5178 | 30.78 | 10.41 | 2.34 | 41.31 | 4.49 | 16.60 | -10.42 |
Solventum Corp | 8.21bn | 1.06bn | 12.40bn | 22.01k | 11.02 | 4.07 | 7.69 | 1.51 | 6.13 | 6.13 | 47.50 | 16.60 | 0.5817 | 3.97 | 7.36 | 372,926.80 | 7.50 | -- | 8.72 | -- | 56.98 | -- | 12.89 | -- | 0.9584 | 10.03 | 0.7434 | -- | 0.8241 | -- | 0.2234 | -- | -- | -- |
Davita Inc | 12.52bn | 859.62m | 13.86bn | 70.00k | 17.36 | 21.92 | 7.32 | 1.11 | 9.40 | 9.40 | 136.76 | 7.44 | 0.7371 | 71.09 | 5.81 | 178,919.40 | 6.74 | 5.62 | 9.10 | 7.45 | 32.72 | 30.70 | 9.15 | 8.33 | 1.12 | 5.26 | 0.7876 | -- | 4.57 | 1.26 | 26.44 | 2.33 | -10.47 | -- |
Universal Health Services, Inc. | 15.02bn | 934.19m | 15.52bn | 73.35k | 16.86 | 2.37 | 10.22 | 1.03 | 13.63 | 13.63 | 218.77 | 97.21 | 1.08 | -- | 7.05 | 204,737.60 | 6.82 | 6.44 | 8.07 | 7.63 | -- | -- | 6.31 | 6.55 | 1.17 | 6.91 | 0.4094 | 6.06 | 6.59 | 5.80 | 6.32 | -1.47 | 1.17 | 14.87 |
Natera Inc | 1.36bn | -292.12m | 15.65bn | 3.28k | -- | 18.54 | -- | 11.50 | -2.47 | -2.47 | 11.38 | 6.78 | 0.9841 | 15.01 | 4.57 | 414,534.80 | -21.13 | -36.17 | -26.88 | -46.60 | 53.85 | 45.88 | -21.47 | -56.15 | 4.01 | -- | 0.3032 | -- | 31.99 | 33.26 | 20.63 | -- | 58.81 | -- |
Tenet Healthcare Corp | 20.92bn | 2.76bn | 15.77bn | 78.14k | 5.97 | 4.50 | 3.59 | 0.7542 | 27.32 | 27.32 | 205.26 | 36.27 | 0.7414 | 9.27 | 6.85 | 267,659.70 | 12.52 | 3.61 | 18.25 | 5.09 | 82.58 | 82.97 | 16.89 | 4.95 | 1.38 | 4.89 | 0.6206 | 0.00 | 7.17 | 2.33 | 49.02 | 41.42 | 4.01 | -- |
Quest Diagnostics Inc | 9.35bn | 836.00m | 17.41bn | 40.00k | 20.88 | 2.60 | 13.18 | 1.86 | 7.41 | 7.41 | 82.89 | 59.61 | 0.6845 | 34.23 | 7.32 | 233,650.00 | 6.36 | 9.28 | 7.49 | 10.81 | 32.98 | 36.64 | 9.29 | 12.97 | 0.912 | 8.51 | 0.3963 | 25.07 | -6.38 | 4.20 | -9.77 | 3.40 | 1.27 | 7.43 |
Labcorp Holdings Inc | 12.49bn | 449.50m | 18.96bn | 67.00k | 42.21 | 2.32 | 17.98 | 1.52 | 5.26 | 5.26 | 146.61 | 95.53 | 0.7254 | 19.34 | 5.82 | 186,382.10 | 2.62 | 6.27 | 3.20 | 7.37 | 28.00 | 32.33 | 3.61 | 9.51 | 0.7699 | 6.40 | 0.391 | -- | 2.51 | 1.42 | -62.16 | -16.40 | 3.62 | -- |
Holder | Shares | % Held |
---|---|---|
Berkshire Hathaway, Inc. (Investment Management)as of 06 Aug 2024 | 36.10m | 41.16% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 6.03m | 6.87% |
BlackRock Fund Advisorsas of 31 Mar 2024 | 3.20m | 3.65% |
SSgA Funds Management, Inc.as of 31 Mar 2024 | 2.58m | 2.94% |
Pacer Advisors, Inc.as of 31 Mar 2024 | 1.68m | 1.92% |
Geode Capital Management LLCas of 30 Jun 2024 | 1.26m | 1.44% |
Invesco Capital Management LLCas of 31 Mar 2024 | 1.19m | 1.36% |
LSV Asset Managementas of 30 Jun 2024 | 1.08m | 1.24% |
Dimensional Fund Advisors LPas of 30 Jun 2024 | 878.64k | 1.00% |
Gates Capital Management, Inc.as of 31 Mar 2024 | 762.57k | 0.87% |